Follow Us
https://www.thebody.com/author/john-g-bartlett

Latest by John G. Bartlett

Promo Image

Guilt and Self-Worth

What People Feel Guilty About

One of the many peculiarities of HIV is the amount of guilt it seems to inspire. People feel guilty for having become infected. They feel they are somehow to blame for having gotten the virus, that they brought it on th...

Promo Image
Coping

HIV Infection and Its Effects on the Emotions

An excerpt from The Guide to Living With HIV Infection, provided with the permission of The Johns Hopkins University Press (2006). To purchase the book, click here.

The Guide to Living With HIV Infection

Anger and Energy Depression and Hope Fat...

Promo Image
News

Snapshots of the Literature

Comparison of Three Regimens for Treatment of Mild to Moderate Pneumocystis carinii Pneumonia in Patients with AIDS [Safrin S, et al. Ann Intern Med 1996;124:792]: This is ACTG trial 108 comparing trimethoprim-sulfamethoxazole, dapsone-trimethoprim...

Promo Image
News

Occupational Exposure to HIV: Revised Hopkins Policy

Methods to deal with occupational exposure to HIV are undergoing radical revision as a result of the CDC analysis of risk factors for infection and utility of AZT prophylaxis. The case-control study analyzed data from health care workers from 191 fac...

Promo Image

Profiles on New Drugs

Index

Indinavir Ritonavir Saquinavir Lamivudine (3TC) Amphotericin B Lipid Complex Liposomal Daunorubicin

IndinavirTrade name: Crixivan (Merck Research Laboratories)Form: 100, 200 and 400 mg capsules.Clinical trials: Phase I/II trials sho...

Promo Image

New from the Food and Drug Administration (FDA)

3TC (Lamivudine, Epivir)

On November 17, 1995, the FDA approved 3TC plus AZT as the first new initial treatment option for HIV infection since the approval of AZT in 1987. The specific language in the package inserts is the following: "Epivir is ind...

Promo Image

The Moving Target of Antiretroviral Therapy

The FDA approved 3TC (Lamivudine) and saquinavir in November, 1995, and then approved ritonavir and indinavir on March 1, 1996. This sudden expansion of the armamentarium of drugs for HIV is viewed as a major breakthrough for HIV therapeutics. It i...

Promo Image
News

Profiles on New Drugs

Index

Indinavir Ritonavir Saquinavir Lamivudine (3TC) Amphotericin B Lipid Complex Liposomal Daunorubicin

IndinavirTrade name: Crixivan (Merck Research Laboratories)Form: 100, 200 and 400 mg capsules.Clinical trials: Phase I/II trials sho...